Ditto Bio

Visibility12

Vibe80

AI Visibility & Sentiment

Ditto Bio

Ditto Bio is a Y Combinator-backed biotechnology startup that discovers new drugs for autoimmune diseases by harnessing parasite biology. Their AI platform identifies therapeutic proteins from viruses, ticks, and worms that have evolved to modulate the immune system over millions of years.

Active Monitoring

dittobio.com

Biotechnology YC25-26

AI Visibility Score

12/100

Invisible

Sentiment Score

80/100

AI Perception

Summary

Ditto Bio is currently a ghost in the AI biotech conversation, completely missing from high-intent searches by Big Pharma scouts despite a niche presence in specialized immunology research. While competitors like Exscientia and Recursion dominate the narrative for AI-driven drug discovery, Ditto Bio only surfaces during deep technical inquiries into parasite biology or direct brand vibe checks.

Value Proposition

Leveraging millions of years of parasite evolution to discover novel immunomodulatory proteins that can treat autoimmune diseases where the immune system attacks the body.

Overview

Mission

To discover new drugs by harnessing parasite biology, mining nature's untapped source of immunomodulatory proteins to treat autoimmune diseases.

Products & Services

AI-powered drug discovery platformTherapeutic protein identification from parasitesAutoimmune disease drug candidatesImmunomodulatory protein researchParasite biology analysis

Agent Breakdown

AI Platforms

How often do different AI platforms reference Ditto Bio?

Loading explorer...

Conversation Analysis

Topics

What conversations is Ditto Bio included in — or excluded from?

Loading explorer...

Buyer Personas

Personas

Who does each AI platform recommend Ditto Bio to, and when?

Loading explorer...

Programmatic Testing

Sample Conversations

We programmatically analyze questions that real customers are asking to AI agents and chatbots, extract brand mentions and sentiment, analyze every response, and synthesize the data into an action plan to increase AI visibility.

ChatGPT

Claude

Gemini

AI Overviews

Drug Discovery Innovation & AI Strategy(2 queries)

“who are the leaders in AI-driven drug discovery for autoimmune disorders right now?”

1/4 platforms mentioned

ChatGPT

1.Exscientia

2.Insitro

3.Recursion Pharmaceuticals

4.Atomwise

5.Cyclica

+17 more

Claude

1.DeepMind

2.Alphabet

3.AlphaFold

4.Exscientia

5.Recursion Pharmaceuticals

+9 more

Gemini

1.Exscientia

2.Sanofi

3.BenevolentAI

4.Benevolent Platform

5.Eli Lilly

+18 more

AI Overviews

1.DeepCure

2.DC-15442

3.Genesis Therapeutics

4.GEMS

5.Gilead Sciences

25.Ditto Biosciences

+21 more

“help me find biotech platforms using AI to discover novel immunomodulatory proteins”

0/3 platforms mentioned

Claude

1.Exscientia

2.Generate

3.Absci

4.Generate Biomedicines

5.Recursion Pharmaceuticals

+6 more

Gemini

1.AlphaFold

2.EvolutionaryScale

3.Profluent

4.LabGenius

5.Peptilogics

+10 more

AI Overviews

1.BioMap

2.xTrimo

3.Generate Biomedicines

4.Novartis

5.Amgen

+16 more

Investment And Emerging Biotech Trends(1 query)

“emerging biotech startups using AI to mine nature for new drugs, any specific ones to watch?”

0/4 platforms mentioned

ChatGPT

1.Enveda Biosciences

2.Brightseed

3.Metagenomi

4.Microbiotica

5.Second Genome

+13 more

Claude

1.Genentech

2.Roche

3.Atomwise

4.Exscientia

5.Absci

+7 more

Gemini

1.Enveda Biosciences

2.Basecamp Research

3.UniProt

4.Hexagon Bio

5.Brightseed

+7 more

AI Overviews

1.BioPharma APAC

2.Enveda Biosciences

3.ENV-294

4.ENV-308

5.Kapoose Creek Bio

+5 more

Specialized Research In Parasite Biology(1 query)

“research on using parasite proteins to treat autoimmune disease, which companies are doing this?”

0/4 platforms mentioned

ChatGPT

1.ES-62

2.P28GST

3.Cystatins

4.Sm16

5.Trichuris suis ova

+7 more

Claude

1.Coronado Biosciences

2.Flagship Pioneering

3.TSO

4.Nottingham University

5.Evotec

+2 more

Gemini

1.Parade Therapeutics

2.AIP-1

3.Aravis BioTech

4.Helmintherapeutics

5.United Therapeutics

+5 more

AI Overviews

1.Holoclara

2.Coronado Biosciences

3.Dr Falk Pharma

4.Tanawisa Company Ltd

Evaluating The AI Biotech Landscape(1 query)

“most trusted AI-powered drug discovery platforms in 2026”

0/4 platforms mentioned

ChatGPT

1.Exscientia

2.Schrödinger

3.Atomwise

4.Cyclica

5.AbCellera

+18 more

Claude

1.DeepMind

2.Alphabet

3.AlphaFold

4.Isomorphic Labs

5.Exscientia

+11 more

Gemini

1.Insilico Medicine

2.Pharma.AI

3.Biology42

4.Chemistry42

5.Medicine42

+16 more

AI Overviews

1.Insilico Medicine

2.Pharma.AI

3.PandaOmics

4.Chemistry42

5.InClinico

+13 more

Analysis

Key Insights

What AI visibility analysis reveals about this brand

Strength

Secured the #1 position in AI Overviews for specialized research queries regarding parasite proteins and autoimmune disease treatment.

Strength

Maintains a high average position (2.5) among Senior Immunology Researchers, suggesting strong technical relevance within a narrow scientific niche.

Strength

Successfully maintains brand control in direct queries, achieving #1 rankings across all platforms when users specifically ask 'What do you know about Ditto Bio?'

Gap

Zero percent mention rate on ChatGPT, the most widely used AI platform for strategic research and industry analysis.

Gap

Complete absence from critical category queries like 'emerging biotech startups' and 'most trusted AI-powered drug discovery platforms.'

Gap

Total failure to reach the Big Pharma Strategic Scout persona, who is currently being steered toward competitors like Exscientia, Roche, and Recursion.

Opportunity

Bridge the gap between specialized research and category leadership by positioning 'nature mining' as a superior alternative to synthetic-focused AI drug discovery.

Opportunity

Aggressively target the 'AI-driven drug discovery for autoimmune' query space to disrupt the current dominance of generalist platforms like Insilico Medicine.

Opportunity

Leverage the 30% mention rate among Biotech VCs to build high-authority backlinks that can force inclusion into the knowledge graphs of ChatGPT and Claude.

Technical Health

Site Health for AI Visibility

How well Ditto Bio's website is optimized for AI agent discovery and comprehension.

91/100

17 passed 3 warnings

Audited 2/27/2026

Crawlability83

Can AI bots find your pages?

Technical96

SSL, mobile, doctype basics

On-Page SEO93

Titles, descriptions, headings

Content Quality87

Word count, depth, freshness

Schema Markup85

Structured data for AI comprehension

Social & OG100

Open Graph, Twitter cards

AI Readability100

How well AI can parse your content

Warnings

No robots.txt file found

Create a robots.txt file at your domain root. Optional but recommended.

3 render-blocking resource(s) detected

Consider deferring or async-loading non-critical scripts and stylesheets.

Title is too short (9 characters)

Expand the title to 50-60 characters with descriptive keywords.

Few internal links on this page

Add more internal links to related pages on your site.

Want a full technical audit with AI-specific recommendations?

Run a free visibility scan

Brand Identity

Brand Voice & Style

How AI perceives Ditto Bio's communication style and personality

Ditto Bio communicates with scientific authority while making complex biology accessible and compelling. The brand voice balances academic credibility with startup energy, using nature-inspired storytelling to explain their innovative approach. They speak confidently about their unique methodology—mining parasites for therapeutic proteins—while maintaining an approachable tone that invites collaboration. The communication style is forward-thinking and optimistic, emphasizing the untapped potential of evolutionary biology to solve pressing medical challenges.

Core Tone Traits

Scientifically Authoritative

Grounded in rigorous biology and research, conveying deep expertise in immunology and parasitology

Innovatively Bold

Confidently presenting an unconventional approach—using parasites as drug sources—as a breakthrough opportunity

Accessible & Educational

Making complex scientific concepts understandable through clear analogies and nature-based storytelling

Mission-Driven & Optimistic

Conveying genuine purpose and hope for patients suffering from autoimmune diseases

Competitive Landscape

Related Ecosystem

Related products and services that AI mentions in conversations alongside or instead of Ditto Bio

Exscientia21 mentions

Recursion Pharmaceuticals18 mentions

Insilico Medicine14 mentions

Atomwise12 mentions

Schrödinger12 mentions

BenevolentAI11 mentions

AlphaFold11 mentions

Roche10 mentions

Generate Biomedicines9 mentions

Bristol Myers Squibb9 mentions

Ditto Bio6 mentions

Source Intelligence

Citations

Sources that AI assistants cite. Getting featured here improves visibility.

11 Innovative Companies Using AI for Drug Discovery - Cure.

https://wewillcure.com/insights/company-profiles/ai-and-machine-learning/innovative-companies-using-ai-for-drug-discovery

Referenced in 3 queries

Review

25 Leading AI Companies to Watch in 2025: Transforming ...

https://biopharmaapac.com/analysis/32/5655/25-leading-ai-companies-to-watch-in-2025-transforming-drug-discovery-and-precision-medicine.html

Referenced in 3 queries

Review

Drug Discovery and Delivery Startups funded ... - Y Combinator

https://www.ycombinator.com/companies/industry/drug-discovery-and-delivery

Referenced in 1 query

Review

Pfizer's sixth Flagship deal will use AI to discover autoimmune ...

https://firstwordhealthtech.com/story/5946592

Referenced in 1 query

Review

Autoimmune R&D Partnerships, M&A, Ventures, and IPOs in 2024

https://dealforma.com/autoimmune-rd-partnerships-ma-ventures-and-ipos-in-2024/

Referenced in 1 query

Review

Evaxion expands AI-Immunology™ platform into autoimmune ...

https://www.biospace.com/press-releases/evaxion-expands-ai-immunology-platform-into-autoimmune-diseases

Referenced in 1 query

Review

Ten Companies to Watch in AI Drug Discovery - Alex Philippidis, 2024

https://journals.sagepub.com/doi/full/10.1089/gen.44.12.06

Referenced in 2 queries

Review

Member Companies Advancing AI and Drug Discovery - Biocom

https://www.biocom.org/lifelines-article/innovations/member-companies-advancing-ai-and-drug-discovery/

Referenced in 1 query

Review

41 Best Autoimmune Disease Startups to Watch in 2026

https://www.seedtable.com/best-autoimmune-disease-startups

Referenced in 1 query

Review

8 AI Drug Discovery and Manufacturing Stocks to Buy - Money

https://money.usnews.com/investing/articles/ai-drug-discovery-and-manufacturing-stocks-to-buy

Referenced in 1 query

Review

Top autoimmunity start-ups | VentureRadar

https://www.ventureradar.com/startup/autoimmunity

Referenced in 1 query

Review

Enveda Announces First Candidate Discovered From Nature ...

https://www.businesswire.com/news/home/20241113334257/en/Enveda-Announces-First-Candidate-Discovered-From-Nature-Using-AI-Advances-to-Clinical-Trials

Referenced in 1 query

Review

Content Engineering

Goals & Content Ideas

Ideas to help AI agents better understand the business and be more likely to use Ditto Bio's resources to help users.

Launch Digital PR Campaign in Industry Journals

Address the critical 0% mention rate on ChatGPT by executing a targeted digital PR strategy focused on 'AI-driven nature mining' for drug discovery. This involves securing features and citations in high-authority biotechnology and pharmaceutical journals that LLMs reference as authoritative sources, while amplifying coverage through strategic social media campaigns that reinforce our unique parasite-biology narrative.

How parasites that evolved to evade immune systems are now helping us treat autoimmune diseases

The untapped drug discovery goldmine hiding in ticks, worms, and viruses

Why AI-driven nature mining represents the next frontier in immunotherapy development

From evolutionary biology to breakthrough medicine: the science behind therapeutic protein discovery

What millions of years of parasite evolution can teach us about treating autoimmune conditions

Publish Comprehensive AI Immunotherapy Whitepaper

Bridge the visibility gap with the Big Pharma Scout persona by developing and publishing an authoritative whitepaper on AI's role in discovering novel immunotherapies from biological sources. This technical, category-specific content will establish Ditto Bio as a credible player in AI drug discovery while providing shareable insights for social media that demonstrate our scientific depth and unique methodology.

Mapping the immunomodulatory protein landscape: how AI accelerates discovery from nature

The computational biology behind identifying therapeutic proteins in parasitic organisms

Benchmarking AI approaches to biological drug discovery: where nature mining fits

From parasite genome to therapeutic candidate: an AI-powered discovery pipeline explained

Why biological sources remain underexplored in AI-driven drug discovery programs

Optimize Website for AI Drug Discovery Queries

Compete with Exscientia and Insilico for 'AI drug discovery leader' search visibility by restructuring site architecture and metadata to target high-volume category queries. This technical SEO initiative ensures Ditto Bio appears in AI assistant responses when users search for leaders in the space, supported by social content that drives traffic and reinforces our positioning.

What makes an AI drug discovery platform truly innovative in 2026

Comparing approaches: synthetic AI versus nature-inspired drug discovery methods

The key capabilities every AI drug discovery leader must demonstrate

How to evaluate AI drug discovery companies for partnership potential

Beyond traditional targets: why biological source diversity matters in AI drug discovery

Align All Announcements with Nature-Mining Narrative

Capitalize on the 30% mention rate with VC personas by consistently framing clinical trial news and partnership announcements around our distinctive 'Nature-Mining' value proposition. This unified messaging strategy across press releases and social media reinforces our unique positioning in AI-indexed content, making Ditto Bio the definitive reference for this emerging approach.

Partnership announcement: expanding our nature-mining platform into new therapeutic areas

Clinical milestone update: nature-derived immunomodulators advance toward patient trials

How our latest collaboration validates the nature-mining approach to drug discovery

Investor perspective: why nature-mining represents a paradigm shift in autoimmune treatment

Progress report: what our pipeline reveals about the potential of parasite-derived therapeutics

Content Engineering

Recommended Actions

Execute a digital PR strategy focused on 'AI-driven nature mining' for drug discovery in high-authority industry journals.

With a 0% mention rate on ChatGPT, the brand needs fresh, authoritative third-party data sources to be indexed as a category player.

Impact: High

Develop and publish a comprehensive whitepaper on AI's role in discovering novel immunotherapies from biological sources.

The Big Pharma Scout persona has zero visibility of the brand; technical category-specific content is required to bridge this gap.

Impact: High

Optimize site architecture and metadata to specifically target high-volume 'AI drug discovery leader' queries.

Competitors like Exscientia and Insilico are capturing the lion's share of mentions for general category queries where Ditto Bio is currently non-existent.

Impact: Medium

Align clinical trial news and partnership announcements with the 'Nature-Mining' narrative.

The VC persona shows the most growth potential (30% mention rate); reinforcing this unique value proposition will solidify their interest and drive mentions.

Impact: Medium

Is this your business? We can help you improve your AI visibility.

Book a Free Strategy Session

Backing